s6y
Company name or ticker
Search
Viracta Therapeutics, Inc.
8-K
Material agreement ended; Financial results
Filed
Tuesday, July 28, 2020
Period
Jul 28, 2020
Accession number
0001564590-20-033927
Documents
Current report filing
8-K
On sec.gov
Filing index
All files
Complete submission text
SGML header